Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

DORAL GROUP RENEWABLE ENERGY RESOURCES LTD (DORL)

  • Business News
  • June 23, 2026, 05:49 UTC
  • 2
  • 1 comments

Became an interested party – HAPHOENIX FINANCIALS LTD

Market reaction Comment Full text

G CITY LTD (GCT)

  • Business News
  • June 23, 2026, 05:43 UTC
  • 2
  • 1 comments

Trustee report for BONDS Series 20 for 2025, Strauss Lazar

Market reaction Comment Full text

G CITY LTD (GCT)

  • Business News
  • June 23, 2026, 05:42 UTC
  • 2
  • 1 comments

Annual trustee report for the BONDS Series 14 for 2025 submitted by Strauss Lazar

Market reaction Comment Full text

G CITY LTD (GCT)

  • Business News
  • June 23, 2026, 05:39 UTC
  • 2
  • 1 comments

Annual report of the BONDS trustee (Series 17) for 2025, Strauss Lazar

Market reaction Comment Full text

SHIKUN & BINUI ENERGY LTD (SBEN)

  • Business News
  • June 23, 2026, 05:33 UTC
  • 2
  • 1 comments

Completion of financial closing of the Ashalim PV project, details

Market reaction Comment Full text

F.I.B.I. HOLDINGS LTD. (FIBIH)

  • Business News
  • June 23, 2026, 05:31 UTC
  • 2
  • 1 comments

Banlam – declaration of a labor dispute in the Metaf IT and Financial Operations, details

Market reaction Comment Full text

ELCO LTD (ELCO)

  • Business News
  • June 23, 2026, 05:19 UTC
  • 2
  • 1 comments

Dormant shares - change in the number of shares

Market reaction Comment Full text

BANCO SANTANDER S.A. (SAN)

  • Business News
  • June 23, 2026, 05:15 UTC
  • 2
  • 1 comments

Press Release: Sanofi’s Wayrilz approved in Japan to treat immune thrombocytopenia

Market reaction Comment Full text

BANCO SANTANDER S.A. (SAN)

  • Business News
  • June 23, 2026, 05:15 UTC
  • 2
  • 1 comments

Communiqué de presse : Wayrilz de Sanofi a été approuvé au Japon pour traiter la thrombocytopénie immunitaire

Market reaction Comment Full text

ArgenX Inc (ARGX)

  • Business News
  • June 23, 2026, 05:00 UTC
  • 2
  • 1 comments

argenx to Host Autoimmune Myositis R&D Webinar

Market reaction Comment Full text
  • Previous
  • 3168
  • 3169
  • 3170
  • 3171
  • 3172
  • Next

Search

News categories

  • Technical Exchange News(14408)
  • Event(6229)
  • SEC News(376078)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(229876)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin